Dr. Bruce Bode talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the future of CGMs.
Read More »Bruce Bode Part 7, CGM Impact on Diabetes Treatment
Dr. Bruce Bode talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about his work with type 2 diabetes patients.
Read More »Ahmad Yehya Full Interview
In this Exclusive Interview, Dr. Yehya explains the benefits of bariatric surgery in specific patient populations.
Read More »Ahmad Yehya Transcript
Dr. Ahmad Yehya discusses the benefits of bariatric surgery and how studies have shown it improves outcomes in certain patient populations, specifically patients with BMI between 35 and 40.
Read More »A Unifying Pathophysiologic Approach to The Complications of Diabetes in the Context of the Beta-cell Classification of Diabetes Part 1
In this week's Homerun Slides, an extension of the discussion of the beta-cell classification of diabetes.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #81: Insulin Actions In Vivo: Glucose Metabolism Part 7 of 9
Cellular, biochemical, and molecular mechanisms of insulin action: The insulin receptor is a glycoprotein consisting of two alpha subunits and two beta subunits linked by disulfide bonds and expresses insulin-stimulated kinase activity directed towards its own tyrosine residues. Insulin receptor phosphorylation of the α subunit, with subsequent activation of insulin receptor tyrosine kinase, represents the first step in the action of insulin on glucose metabolism.
Read More »Glucose Self-Monitoring For Non-Insulin Using Patients Did Not Improve Control
The value of self-monitoring of blood glucose (SMBG) levels in patients with non-insulin-treated type 2 diabetes has been debated over the years.
Read More »ADA: Oral Insulin May Delay Type 1 Diabetes Onset
In adults with two or more antibodies predicting the development of type 1 diabetes, treatment with daily oral insulin therapy did not prevent development of the disease, but a small subset experienced a 31-month delay in clinical diabetes development.
Read More »ADA: Broiling, Barbecuing and Roasting Meat May Increase Risk of Diabetes
Chemicals such as heterocyclic amines (HCA) and polycyclic aromatic amines (PAH) found in overcooked meat play a role in the development of type 2 diabetes (T2D).
Read More »Statins and Exercise: Revisited
I chronicled someone with type 1 diabetes whose ability to exercise was compromised by his use of statins back in April 2016. As you know, statins are a class of medications prescribed to lower cholesterol levels or abnormal levels of blood fats, with the goal being a reduction in the risk of heart attack and stroke. Brand name examples of statin medications include Altoprev, Crestor, Lescol, Lipitor, Livalo, Mevacor, Pravachol, and Zocor.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.